Christoph Bausch
Fortuna: - $ al 30/06/2026
Fortuna: - $ al 30/06/2026
Christoph Bausch is the founder of Nanopore Diagnostics LLC.
Dr. Bausch is the Chief Operating Officer at SAB Biotherapeutics, Inc. since 2022.
Dr. Bausch attended the University of Nebraska for undergraduate studies, St. Louis University for an MBA, and The Ohio State University for a doctorate.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Director de Operaciones | 01/05/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Nanopore Diagnostics LLC
Nanopore Diagnostics LLC Medical SpecialtiesHealth Technology Develops portable platform for counting microbes | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
University of Nebraska
University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Louis University
St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanopore Diagnostics LLC
Nanopore Diagnostics LLC Medical SpecialtiesHealth Technology Develops portable platform for counting microbes | Health Technology |
SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.